KK-LC-1 may be an effective prognostic biomarker for gastric cancer
Open Access
- 12 March 2021
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 21 (1) , 1-8
Abstract
Background: The objective of the study was to detect the expression of Kita-Kyushu lung cancer antigen-1 (KK-LC-1) in gastric cancer (GC) specimens and analyse the associations between KK-LC-1 expression and clinicopathological parameters and clinical prognosis. Methods: All of the 94 patients in this study were GC patients who underwent surgical resection. KK-LC-1 protein expression in GC tissue was detected by immunohistochemistry. This report applies the histological score (H-score) to evaluate KK-LC-1 expression. To calculate this indicator, the number of positive cells in each section and their staining intensity were converted to corresponding values. The expression of KK-LC-1 in the cytoplasm of cancer and normal tissues was scored to obtain their respective H values. The chi-square test, Kaplan-Meier method and Cox regression were used to analyse the linear association between KK-LC-1 expression and clinicopathological data and prognosis. Results: In the cytoplasm, KK-LC-1 expression in tumour tissues was significantly higher than that in normal tissues (P < 0.001). Using the median H-score as the cut-off value, we discovered that GC patients with high levels of KK-LC-1 expression in the cytoplasm had favourable overall survival (OS) (P = 0.016), and this result was statistically significant in the Cox regression analysis. Additionally, a negative correlation was found between KK-LC-1 protein expression and the pathological grade of the tumour (P = 0.036), with significantly more KK-LC-1 protein expression observed in the intestinal type of GC than in the diffuse type (P = 0.008). Conclusions: Our research data showed that KK-LC-1 expression was greater in GC tissues than in normal tissues, and higher KK-LC-1 expression was associated with longer OS of GC patients. KK-LC-1 can be used as a biomarker for a good prognosis in GC patients.Keywords
All Related Versions
Funding Information
- Research Program of Science and Technology at Universities of Inner Mongolia Autonomous Region (NJZZ18184)
This publication has 36 references indexed in Scilit:
- Clinical Impact of the Extent of Lymph Node Micrometastasis in Undifferentiated-Type Early Gastric CancerOncology, 2014
- MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomasLaboratory Investigation, 2013
- BCL6 overexpression is associated with decreased p19ARF expression and confers an independent prognosticator in gallbladder carcinomaTumor Biology, 2013
- MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTENCancer Cell International, 2013
- Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritisInternational Journal of Cancer, 2012
- Clinical Significance of Melanoma Antigen-Encoding Gene-1 (MAGE-1) Expression and its Correlation with Poor Prognosis in Differentiated Advanced Gastric CancerAnnals of Surgical Oncology, 2010
- Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancerInternational Journal of Cancer, 2006
- Cancer/testis antigens, gametogenesis and cancerNature Reviews Cancer, 2005
- Helicobacter pylori and molecular events in precancerous gastric lesionsAlimentary Pharmacology & Therapeutics, 2004
- Identification of tumour antigens by serological analysis of cDNA expression cloningCancer Immunology, Immunotherapy, 2004